Search Page

1

Cite

Share

Lipoatrophia semicircularis - a distinct entity?

Sigl J, Lázár M, Tittes J, Wendt J, Kancz S, Kiefer FW, Valencak J, Okamoto I, Lichtenberger BM, Handisurya A. Sigl J, et al. Among authors: valencak j. Int J Dermatol. 2020 Nov;59(11):e385-e387. doi: 10.1111/ijd.15138. Epub 2020 Aug 17. Int J Dermatol. 2020. PMID: 32808284 No abstract available.

Cite

Share

2

Cite

Share

Contact allergy to methylisothiazolinone with three clinical presentations in one patient.

Gorris A, Valencak J, Schremser V, Bangert C, Kinaciyan T. Gorris A, et al. Among authors: valencak j. Contact Dermatitis. 2020 Mar;82(3):162-164. doi: 10.1111/cod.13384. Epub 2019 Aug 27. Contact Dermatitis. 2020. PMID: 31403207 Free PMC article. No abstract available.

Cite

Share

3

Cite

Share

Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study.

Brüggen MC, Valencak J, Stranzenbach R, Li N, Stadler R, Jonak C, Bauer W, Porkert S, Blaschke A, Meiss F, Nicolay JP, Wehkamp U, Schlaak M, Nguyen VA, Romani N, Cozzio A, Gayathri N, Dimitriou F, French LE, Dummer R, Guenova E. Brüggen MC, et al. Among authors: valencak j. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1489-1495. doi: 10.1111/jdv.16215. Epub 2020 Mar 10. J Eur Acad Dermatol Venereol. 2020. PMID: 31955469 Free article.

Cite

Share

4

Cite

Share

Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas.

Porkert S, Lehner-Baumgartner E, Valencak J, Knobler R, Riedl E, Jonak C. Porkert S, et al. Among authors: valencak j. Acta Derm Venereol. 2018 Feb 7;98(2):240-245. doi: 10.2340/00015555-2819. Acta Derm Venereol. 2018. PMID: 29048099 Free article.

Cite

Share

5

Cite

Share

Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma.

Porkert S, Mai P, Jonak C, Weihsengruber F, Rappersberger K, Bauer W, Simonitsch-Klupp I, Raderer M, Valencak J. Porkert S, et al. Among authors: valencak j. Acta Derm Venereol. 2021 Feb 2;101(2):adv00383. doi: 10.2340/00015555-3746. Acta Derm Venereol. 2021. PMID: 33475146 Free article.

Cite

Share

6

Cite

Share

Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine.

Valencak J, Trautinger F, Fiebiger WC, Raderer M. Valencak J, et al. Ann Hematol. 2002 Nov;81(11):662-5. doi: 10.1007/s00277-002-0554-4. Epub 2002 Oct 29. Ann Hematol. 2002. PMID: 12454707 Review.

Cite

Share

7

Cite

Share

Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma.

Valencak J, Dietrich W, Raderer M, Dieckmann K, Prayer D, Hainfellner JA, Marosi C. Valencak J, et al. J Neurooncol. 2000 Sep;49(3):263-8. doi: 10.1023/a:1006405106553. J Neurooncol. 2000. PMID: 11212906 Review.

Cite

Share

8

Cite

Share

Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas.

Valencak J, Trautinger F, Raderer M, Chott A, Der-Petrossian M, Ivancic-Brandenberger E, Knobler R, Kurtaran A, Hoffmann M. Valencak J, et al. J Eur Acad Dermatol Venereol. 2010 Jan;24(1):13-7. doi: 10.1111/j.1468-3083.2009.03330.x. Epub 2009 Jun 8. J Eur Acad Dermatol Venereol. 2010. PMID: 19515078

Cite

Share

9

Cite

Share

Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma.

Valencak J, Kittler H, Schmid K, Schreiber M, Raderer M, Gonzalez-Inchaurraga M, Birner P, Pehamberger H. Valencak J, et al. Clin Exp Dermatol. 2009 Dec;34(8):e962-4. doi: 10.1111/j.1365-2230.2009.03706.x. Clin Exp Dermatol. 2009. PMID: 20055873

Cite

Share

10

Cite

Share

Carbamazepine-induced DRESS syndrome with recurrent fever and exanthema.

Valencak J, Ortiz-Urda S, Heere-Ress E, Kunstfeld R, Base W. Valencak J, et al. Int J Dermatol. 2004 Jan;43(1):51-4. doi: 10.1111/j.1365-4632.2004.01832.x. Int J Dermatol. 2004. PMID: 14693022 No abstract available.

Cite

Share